Want to join the conversation?
$LM said it has reinstated its existing buyback program effective March 22, 2016, retroactive to Feb. 1, 2016. Specifically, the company expects to resume its $90MM quarterly buyback pace in 1Q17 and to buyback $60MM of its stock related to its 4Q16. The acquisitions of Clarion Partners and EnTrust Capital are likely to close in $LM's 1Q17.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.